| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |